Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy
- PMID: 12081993
- DOI: 10.1161/01.cir.0000019070.70491.6d
Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy
Abstract
Background: Unexplained left ventricular hypertrophy (LVH) is considered diagnostic of hypertrophic cardiomyopathy (HCM) but fails to identify all genetically affected individuals. Altered diastolic function has been hypothesized to represent an earlier manifestation of HCM before the development of LVH; however, data regarding the clinical utility of imaging techniques that assess this parameter are limited.
Methods and results: Echocardiographic studies including Doppler tissue imaging (DTI) were performed in a genotyped HCM population with beta-myosin heavy chain (beta -MHC) mutations. Genotype (+) individuals with LVH (G+/LVH+; n=18) and genotype (+) individuals without LVH (G+/LVH-; n=18) were compared with normal control subjects (n=36). Left ventricular ejection fraction (EF) was significantly higher in both genotype (+) groups (75+/-5% and 71+/-6%, respectively, versus 64+/- 5% in control subjects; P<0.0001). Mean early diastolic myocardial velocities (Ea) were significantly lower in both genotype (+) subgroups, irrespective of LVH (P<0.02). However, there was substantial overlap in Ea velocities between the G+/LVH- and control groups. An Ea velocity of < or =13.5 cm/s had 86% specificity and 75% sensitivity for identifying genotype-positive subjects. The combination of EF > or =68% and Ea velocity <15 cm/s was 100% specific and 44% sensitive in predicting affected genotype.
Conclusions: Abnormalities of diastolic function assessed by Doppler tissue imaging precede the development of LVH in individuals with HCM caused by beta -MHC mutations. Although Ea velocity alone was not sufficiently sensitive as a sole diagnostic criterion, the combination of Ea velocity and EF was highly predictive of affected genotype in individuals without overt manifestations of HCM.
Comment in
-
Disrobing the emperor (heart) without destroying the dignity of super-normality.Circulation. 2002 Jun 25;105(25):2934-6. doi: 10.1161/01.cir.0000021163.86906.b2. Circulation. 2002. PMID: 12081981 No abstract available.
Similar articles
-
Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.JACC Cardiovasc Imaging. 2009 Jan;2(1):58-64. doi: 10.1016/j.jcmg.2008.08.003. JACC Cardiovasc Imaging. 2009. PMID: 19356534
-
Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy.Circulation. 2000 Sep 19;102(12):1346-50. doi: 10.1161/01.cir.102.12.1346. Circulation. 2000. PMID: 10993850 Free PMC article.
-
Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging.Eur Heart J. 2010 Jul;31(13):1599-607. doi: 10.1093/eurheartj/ehq101. Epub 2010 May 3. Eur Heart J. 2010. PMID: 20439259
-
Diastolic Dysfunction of Hypertrophic Cardiomyopathy Genotype-Positive Subjects Without Hypertrophy Is Detected by Tissue Doppler Imaging: A Systematic Review and Meta-analysis.J Ultrasound Med. 2017 Oct;36(10):2093-2103. doi: 10.1002/jum.14250. Epub 2017 Jun 6. J Ultrasound Med. 2017. PMID: 28586098 Review.
-
[Tissue Doppler imaging and ultrasonic methods for evaluating myocardial deformation in the diagnosis of hypertrophic cardiomyopathy].Kardiologiia. 2014;54(7):79-84. doi: 10.18565/cardio.2014.7.79-84. Kardiologiia. 2014. PMID: 25177818 Review. Russian.
Cited by
-
Hypertrophic cardiomyopathy in 2012.Circulation. 2012 Mar 20;125(11):1432-8. doi: 10.1161/CIRCULATIONAHA.110.017277. Circulation. 2012. PMID: 22431884 Free PMC article. Review. No abstract available.
-
Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy.Int J Mol Sci. 2022 Feb 16;23(4):2195. doi: 10.3390/ijms23042195. Int J Mol Sci. 2022. PMID: 35216312 Free PMC article. Review.
-
Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.Ann Intern Med. 2010 Apr 20;152(8):513-20, W181. doi: 10.7326/0003-4819-152-8-201004200-00008. Ann Intern Med. 2010. PMID: 20404382 Free PMC article. Review.
-
The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.J Cardiovasc Transl Res. 2009 Dec;2(4):349-67. doi: 10.1007/s12265-009-9137-2. Epub 2009 Oct 27. J Cardiovasc Transl Res. 2009. PMID: 20559994 Review.
-
Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.Pflugers Arch. 2015 Jun;467(6):1303-17. doi: 10.1007/s00424-014-1570-7. Epub 2014 Jul 11. Pflugers Arch. 2015. PMID: 25010737
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials